UBS downgraded Mobileye Global (NASDAQ:MBLY) to Neutral with a price target of $14, citing a longer-than-expected return to growth. Challenges include delayed SuperVision system growth and lower unit sales forecasts.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing